Skip to search.
 FTSE 100 Up 0.33%

AbbVie Inc. (ABBV)

-NYSE
61.54 Up 0.64(1.05%) 9 Dec 21:01
|After Hours: : 61.55 Up 0.01 (0.02%) 10 Dec 00:54
Prev Close:60.90
Open:61.52
Bid:61.50 x 200
Ask:61.55 x 100
1y Target Est:69.95
Beta:1.52098
Earnings Date:27 Jan - 31 Jan (Est.)
Day's Range:60.92 - 61.92
52wk Range:50.71 - 68.12
Volume:7,102,861
Avg Vol (3m):7,691,560
Market Cap:100.01b
P/E (ttm):16.64
EPS (ttm):3.70
Div & Yield:2.56 (4.15%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for ABBV at this time.

Comparison

Symbol% ChgMkt Cap
ABBVUp 1.05%100.01b
1 0.00%N/A
PFEUp 2.46%192.37b
MRKUp 1.85%168.82b

Key Statistics

Forward P/E (1 yr):11.19
P/S (ttm):3.92
Ex-Dividend Date:11-Jan-17

Analysts

Annual EPS Est (Dec-16) :4.82
Quarterly EPS Est (Dec-16) :1.19
Mean Recommendation*:2.5
PEG Ratio (5 yr expected):0.83

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceutical products worldwide. The company offers HUMIRA, a biologic therapy administered as a subcutaneous injection to treat autoimmune diseases; IMBRUVICA, an oral therapy for the tre... more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback